Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
German foreign minister backs abandoning EU's unanimity principle - 2The Most Vital Crossroads in Olympic History
- 3Vote in favor of Your #1 4K television: Lucidity and Drenching Matter
- 45 Affordable Travel Destinations To Visit In South America
- 5The ‘Stranger Things’ finale, explained: What happens to Vecna? And why was a key character’s fate left unknown?
- Orbán orders stop to gas deliveries to Ukraine via Hungary from July
- NASA just launched Artemis 2. What happens today could make or break the moon mission
- An 'explosion' of solo-agers are struggling with rising costs and little support: 'I'm flying without a net'
- Inside Plan with Houseplants: An Aide
- NASA will bring space station crew home early after medical issue
- Hezbollah sees potential win as Israel backs down from disarmament goal
- Change Your Physical make-up: Compelling Activities for Muscle Building
- Texas cities have some of the highest preterm birth rates in the US, highlighting maternal health crisis nationwide
- UAE recalls some Nestle infant formula products, Qatar warns consumers
